Serum alpha-feto-protein and primary cancer of the liver in man

Abstract

Cases with abnormal liver function tests, Bantu blood donors, neonates, Caucasian patients with primary cancer of the liver, and male Bantu mine workers with primary cancer of the liver have been investigated by means of a quantitative alpha-feto-protein (AFP) immunodiffusion assay. No false-positive AFP tests have occurred, and 78% of primary liver cancer patients are positive. More sensitive tests are capable of increasing the positivity rate still further.